Rezūm™: yay or nay? From the patients’ perspective: a patient reported outcome measure (PROM) study from a single UK centre
DOI:
https://doi.org/10.51496/jogm.v2.71Abstract
Background: RezūmTM steam ablation therapy is an effective minimally invasive surgical therapy for the treatment of symptomatic benign prostatic hyperplasia. The aim of this study was to assess the perception of this treatment from the patients’ perspective at a single centre.
Methods: A patient reported outcome measure (PROM) questionnaire was sent to 65 consecutive patients at least 6 months after undergoing RezūmTM therapy. We evaluated changes in their prostate symptoms, quality of life (QoL) as well as new onset sexual dysfunction.
Results: A total of 44 questionnaires were analysed with a response rate of 67.7%. Mean prostate volume was 62 mL in a mean population age of 68 years. There was a significant improvement in mean International Prostate Symptom Score and QoL scores (P < 0.0001). There was a higher rate of de novo sexual dysfunction noted as compared to other studies. Retreatment procedures occurred in 4.3% of patients, whilst 88.9% reported being medication free. Thirty-five (79.5%) respondents will recommend the procedure.
Conclusions: This study highlighted that the beneficial effects of RezūmTM observed clinically were also perceived positively by patients in a real-world setting, which is just as equally important.
References
2.
National Institute of Health and Care Excellence. Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia. Medical technologies guidance MTG49. London: NICE; 2020. Available from: www.nice.org.uk/guidance/mtg49/resources/rezum-for-treating-lower-urinary-tract-symptoms-secondary-tobenign-prostatic-hyperplasia-pdf-64372064176069 [cited 23 September 2022].
3.
McVary KT, Gittelman MC, Goldberg KA, Kalpesh P, Shore ND, Levin RM, et al. Final 5-year outcomes of the multicenter randomized sham controlled trial of Rezum water vapor thermal therapy for treatment of moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2021; 206: 715–24. doi: 10.1097/JU.0000000000001778 DOI: https://doi.org/10.1097/JU.0000000000001778
4.
Miller LE, Chughtai B, McVary K, Gonzalez RR, Rojanasarot S, DeRouen K, et al. Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: systematic review and meta-analysis. Medicine 2020; 99: e21365. doi: 10.1097/MD.0000000000021365 DOI: https://doi.org/10.1097/MD.0000000000021365
5.
Dixon CM, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, et al. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol 2016; 8: 207–16. doi: 10.2147/RRU.S119596 DOI: https://doi.org/10.2147/RRU.S119596
6.
Darson MF, Alexander EE, Schiffman ZJ, Lewitton M, Light RA, Sutton MA, et al. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezum system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol 2017; 9: 159–68. doi: 10.2147/RRU.S143679 DOI: https://doi.org/10.2147/RRU.S143679
7.
Mynderse LA, Hanson D, Robb RA, Pacik D, Vit V, Varga G, et al. Rezum system water vapor treatment for lower urinary tract symptoms/benign prostatic hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional renderings. Urology 2015; 86: 122–7. doi: 10.1016/j.urology.2015.03.021 DOI: https://doi.org/10.1016/j.urology.2015.03.021
8.
McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Minimally invasive prostate convective water vapour energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2016; 195: 1529–38. doi: 10.1016/j.juro.2015.10.181 DOI: https://doi.org/10.1016/j.juro.2015.10.181
9.
Mollengarden D, Goldberg K, Wong D, Roehrborn C. Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience. Prostate Cancer Prostat Dis 2018; 21: 379–85. doi: 10.1038/s41391-017-0022-9 DOI: https://doi.org/10.1038/s41391-017-0022-9
10.
Alegorides C, Fourmarier M, Eghazarian C, Lebdai S, Chevrot A, Droupy S. Treatment of benign prostate hyperplasia using the Rezum water vapor therapy system: results at one year. Prog Urol 2020; 30: 624–31. doi: 10.1016/j.purol.2020.05.004 DOI: https://doi.org/10.1016/j.purol.2020.05.004
11.
Whiting D, Noureldin M, Abdelmotagly Y, Butler D, Gehring T, Nedas T, et al. Rezum water vapour therapy: understanding retreatment. Eur Urol 2021; 79: S81. doi: 10.1016/S0302-2838(21)00447-4 DOI: https://doi.org/10.1016/S0302-2838(21)00447-4
Published
How to Cite
License
Copyright (c) 2022 Abisola E. Oliyide, Adebanji A.B. Adeyoju
This work is licensed under a Creative Commons Attribution 4.0 International License.
Journal of Global Medicine | Editor-in-Chief: Olufunso Adedeji. MBBS, MD, FRCSEd. 
